24.07.2013 Views

Kostråd for å fremme folkehelsen og forebygge kroniske ... - NRK

Kostråd for å fremme folkehelsen og forebygge kroniske ... - NRK

Kostråd for å fremme folkehelsen og forebygge kroniske ... - NRK

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Dokumentasjon <strong>for</strong><br />

<strong>å</strong>rsakssammenheng<br />

Class I/III, level A/B<br />

(Årsakssammenheng<br />

usannsynlig)<br />

4. Prinsipper <strong>og</strong> metodol<strong>og</strong>i som ligger til grunn <strong>for</strong> de norske kostr<strong>å</strong>dene<br />

Redusert risiko Økt risiko<br />

Eksponering Sykdom Eksponering Sykdom<br />

Folattilskudd, alene eller<br />

sammen med vitamin B6 <strong>og</strong><br />

B12 (29)<br />

Antioksidanttilskudd (vitamin<br />

E, C <strong>og</strong> betakaroten) (29)<br />

Hjerte- <strong>og</strong> karsykdommer<br />

(kvinner)<br />

Hjerte- <strong>og</strong> karsykdommer<br />

(kvinner)<br />

American Diabetes Association<br />

American Diabetes Association har utarbeidet en metodemanual som benyttes ved utarbeidelse av<br />

anbefalinger (32). Metodene er spesielt rettet mot effekter av intervensjoner <strong>og</strong> klinisk behandling,<br />

<strong>og</strong> RCTer tillegges der<strong>for</strong> størst vekt. Selv om konklusjonene fra slik litteraturgjennomgang ofte vil<br />

underestimere den <strong>for</strong>ebyggende effekten av livsstilsfaktorer, er det valgt <strong>å</strong> benytte American Diabetes<br />

Association rapportene som bruker denne metodol<strong>og</strong>ien. For <strong>å</strong> karakterisere <strong>for</strong>skningsmessig status<br />

brukes kategoriene som er beskrevet i aktaboks 4.5.<br />

Faktaboks 4.6. Kategorisering benyttet av American Diabetes Association<br />

Level A<br />

Clear evidence from well-conducted, generalizable, RCTs that are adequately powered, including:<br />

● Evidence from a well-conducted multicenter trial<br />

● Evidence from a meta-analysis that incorporated quality ratings in the analysis<br />

Compelling nonexperimental evidence, i.e., “all or none” rule developed by the Centre <strong>for</strong><br />

Evidence-Based Medicine at Ox<strong>for</strong>d<br />

Supportive evidence from well-conducted RCTs that are adequately powered, including:<br />

● Evidence from a well-conducted trial at one or more institutions<br />

● Evidence from a meta-analysis that incorporated quality ratings in the analysis<br />

Level B<br />

Supportive evidence from well-conducted cohort studies, including:<br />

● Evidence from a well-conducted prospective cohort study or registry<br />

● Evidence from a well-conducted meta-analysis of cohort studies<br />

Supportive evidence from a well-conducted case-control study<br />

Level C<br />

Supportive evidence from poorly controlled or uncontrolled studies, including:<br />

● Evidence from RCTs with one or more major or three or more minor methodol<strong>og</strong>ical flaws<br />

that could invalidate the results<br />

● Evidence from observational studies with high potential <strong>for</strong> bias (such as case series with<br />

comparison with historical controls)<br />

● Evidence from case series or case reports Conflicting evidence with the weight of evidence<br />

supporting the recommendation<br />

Level E<br />

Expert consensus or clinical experience<br />

31

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!